Tnf Pharmaceuticals earnings were -$27.2M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest TNFA earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$3.1M, up 17% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, TNFA reported annual earnings of -$27.2M, with 230.5% growth.
Tnf Pharmaceuticals Earnings Reports & History FAQ
What were Tnf Pharmaceuticals's earnings last quarter?
Tnf Pharmaceuticals (NASDAQ: TNFA) reported Q4 2024 earnings per share (EPS) of -$0.66, up 78.36% year over year. Total TNFA earnings for the quarter were -$3.14 million. In the same quarter last year, Tnf Pharmaceuticals's earnings per share (EPS) was -$3.05.
Is Tnf Pharmaceuticals profitable or losing money?
As of the last Tnf Pharmaceuticals earnings report, Tnf Pharmaceuticals is currently losing money. Tnf Pharmaceuticals's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$23.36 million, a 483.99% increase year over year.
What was TNFA's earnings growth in the past year?
As of Tnf Pharmaceuticals's earnings date in Q2 2025, Tnf Pharmaceuticals's earnings has grown year over year. TNFA earnings in the past year totalled -$27.16 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.